NIH halts study of Eli Lilly antibody drug for treating hospitalized COVID patients | The Hill: Healthcare Policy

Federal researchers have ended a study into the effectiveness of Eli Lilly's antibody treatment for hospitalized COVID-19 patients due to a lack of effectiveness.The National Institute of Allergy and Infectious Diseases (NIAID), which is funding the...